Aprogen Biologics(KR:003060)
₩1,307.000.00 (0.00%)
KR:003060
Aprogen Biologics financials statements
₩1,307.00
At close:0.00 (0.00%)
Want to see KR:003060 full AI Analyst Report?
Aprogen Biologics (003060) Income Statement
Aprogen Biologics Income Statement
Last quarter (Q2 2026), Aprogen Biologics's total revenue was ₩23.08B, an increase of 54.93% from the same quarter last year. In Q2, Aprogen Biologics's net income was ₩-13.98B. See Aprogen Biologics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 73.23B | ₩ 67.38B | ₩ 87.36B | ₩ 65.19B | ₩ 56.48B | |
| ₩ -28.42B | ₩ -7.58B | ₩ -12.05B | ₩ 27.29B | ₩ 25.44B | |
| ₩ 94.47B | ₩ 45.24B | ₩ 58.64B | ₩ 33.00B | ₩ 29.24B | |
| Depreciation and Amortization | ₩ 19.18B | ₩ 19.09B | ₩ 21.40B | ₩ 2.40B | ₩ 2.07B |
| ₩ -103.70B | ₩ -51.33B | ₩ -88.32B | ₩ 17.56B | ₩ 11.93B | |
| ₩ -122.89B | ₩ -52.82B | ₩ -69.95B | ₩ 12.81B | ₩ 10.49B | |
| ₩ -46.49B | ₩ -52.16B | ₩ -43.43B | ₩ 20.31B | ₩ 13.63B | |
| ₩ -169.38B | ₩ -104.98B | ₩ -113.38B | ₩ 6.84B | ₩ 9.83B | |
| ₩ -170.33B | ₩ -104.98B | ₩ -118.27B | ₩ 5.58B | ₩ 8.10B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ -12923.54 | ₩ -12518.74 | ₩ -21305.70 | ₩ 1560.27 | ₩ 2278.71 |
| Diluted EPS | ₩ -12931.00 | ₩ -12518.74 | ₩ -21305.70 | ₩ 1560.27 | ₩ 2278.71 |
| Weighted Average Shares Outstanding | 13.23M | 8.39M | 5.55M | 3.58M | 3.56M |
| Weighted Average Shares Outstanding (Diluted) | 13.23M | 8.39M | 5.55M | 3.58M | 3.56M |
Currency in KRW
